Jared M. Fine, PhD
Research Associate, Center for Memory & Aging
About

Education and training: PhD, physiology, University of Minnesota, Minneapolis; MS, University of Minnesota.

Overview/research interests: Development of intranasal drug-delivery technologies for the treatment of neurodegenerative diseases.

Current research activities and funding:

  • Efficacy and biochemical mechanisms of treatment with intranasal deferoxamine and insulin in models of Alzheimer’s and Parkinson’s disease
  • Mechanisms of delivery from the nasal cavity to the brain
Affiliation
positions
  • Research Associate, Neuroscience Research Centers 2006 -
    • Publications While At 开云体育
    selected publications
    Journal Article
  • Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer's disease. 
    Frontiers in Neuroscience. 2025
  • Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement. 
    Brain and behavior. 2020
  • Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. 
    Neuroscience Letters. 2020
  • Intranasal coadministration of a diazepam prodrug with a converting enzyme results in rapid absorption of diazepam in rats. 
    Journal of Pharmacology and Experimental Therapeutics. 2019
  • Quantifying intranasally administered deferoxamine in rat brain tissue with mass spectrometry. 
    ACS Chemical Neuroscience. 2019
  • Rescue therapies for seizure emergencies: new modes of administration. 
    Epilepsia. 2018
  • Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease. 
    Journal of the Neurological Sciences. 2017
  • Food consumption and activity levels increase in rats following intranasal Hypocretin-1. 
    Neuroscience Letters. 2016
  • Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. 
    Neuroscience Letters. 2015
  • . 2008;157:908-25]. 
    Neuroscience. 2014
  • Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinsons disease. 
    Brain Research. 2014
  • Intranasal administration of CNS therapeutics to awake mice. 
    Journal of visualized experiments. 2013
  • Detection of postoperative sleep-disordered breathing using a portable monitoring device. 
    Sleep & breathing = Schlaf & Atmung. 2012
  • Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice. 
    Experimental Brain Research. 2012
  • Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice. 
    Drug delivery and translational research. 2012
  • Intranasal delivery of growth differentiation factor 5 to the central nervous system. 
    Drug delivery. 2012
  • Production and fate of the sea lamprey migratory pheromone. 
    Fish Physiology and Biochemistry. 2010
    • Conference Paper
  • Improvement of spatial memory in aged APP/PS1 mice with intranasal administration of deferoxamine
    2007
    • Conference Poster
  • Pharmacokinetics of a diazepam prodrug/enzyme combination following nasal administration in rats for treatment of seizure emergencies [poster]
    2015
  • Detection of deferoxamine using liquid chromatography/mass spectrometry with electrospray ionization [poster]
    2013
  • Intranasally administered deferoxamine induces neuroprotection in a 6-OHDA model of Parkinson's disease [poster]
    2013
  • Intranasally administered deferoxamine induces neuroprotection in a 6-OHDA model of Parkinson's disease [poster]
    2013
  • Intranasal deferoxamine treatment in a rat model of Parkinsons disease: preliminary results [poster]
    2012
  • Intranasal deferoxamine improves memory and decreases GSK3B activity in C57 mice [poster]
    2010
    • Review
  • Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease [review]. 
    Pharmaceuticals (Basel, Switzerland). 2021
    • Abstract
  • Delivery of therapeutics via the intranasal route for the treatment of neurodegenerative diseases [abstract]. 
    Neurotherapeutics. 2015
  • Intranasally administered deferoxamine improves spatial memory in APP/PS1 mice [abstract] Alzheimers Deme
    2007
    • Document
  • Intranasal delivery of GDF5 lipid nanosphere formulation
    2007
    • presentations
    Contact
    full name
  • Jared M. Fine, PhD
    • primary email
    located in facility
    Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration
    Contact Information